Financial Comparison: Stryker (SYK) versus The Competition

Stryker (NYSE:SYK – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Stryker to related businesses based on the strength of its analyst recommendations, valuation, dividends, institutional ownership, earnings, risk and profitability.

Dividends

Stryker pays an annual dividend of $3.52 per share and has a dividend yield of 1.1%. Stryker pays out 37.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.5% of their earnings in the form of a dividend. Stryker has raised its dividend for 32 consecutive years.

Analyst Ratings

This is a summary of current recommendations for Stryker and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stryker 0 7 21 0 2.75
Stryker Competitors 4302 10596 18377 837 2.46

Stryker presently has a consensus price target of $342.19, suggesting a potential upside of 10.72%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.71%. Given Stryker’s peers higher possible upside, analysts plainly believe Stryker has less favorable growth aspects than its peers.

Insider and Institutional Ownership

77.1% of Stryker shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 4.6% of Stryker shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Stryker and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stryker 13.78% 23.74% 11.64%
Stryker Competitors -300.62% -179.55% -22.71%

Risk and Volatility

Stryker has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Stryker’s peers have a beta of 5.49, meaning that their average stock price is 449% more volatile than the S&P 500.

Valuation & Earnings

This table compares Stryker and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Stryker $26.30 billion $3.25 billion 32.91
Stryker Competitors $1.89 billion $136.85 million 5.96

Stryker has higher revenue and earnings than its peers. Stryker is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Stryker beats its peers on 10 of the 15 factors compared.

Stryker Company Profile

(Get Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.